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Summary  Chondrocytes  play  an  essential  role  in  endochondral  bone  development,  which  is
requisite for  mammalian  skeletal  development.  During  endochondral  bone  development,  chon-
drocytes undergo  well-organized  stages  of  sequential  differentiation,  including  proliferation
and hypertrophy,  a  process  harmoniously  modulated  by  various  transcription  factors.  Epigenet-
ics, including  DNA  methylation  and  histone  modiﬁcation,  has  recently  emerged  as  an  essential
regulatory  system  for  gene  expression,  not  only  in  physiological  conditions,  but  also  in  human
disease. During  chondrocyte  differentiation,  transcriptional  co-regulators,  which  form  trans-
criptional  protein  complexes  with  speciﬁc  transcription  factors,  are  predominantly  involved  in
this epigenetic  process  and  cooperatively  regulate  chondrocyte  gene  expression.  Importantly,
several  studies  indicate  that  epigenetic  regulators  correlate  with  cartilage-related  diseases,
such as  osteoarthritis,  and  are  noted  as  a  potential  therapeutic  target.  Here,  current  studies
of epigenetic  regulation  of  chondrocyte  differentiation  are  reviewed  and  novel  aspects  for  the
molecular mechanisms  involved  in  chondrogenesis  are  introduced.
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. Introduction
pigenetics  has  recently  emerged  as  an  essential  regulatory
ystem  for  gene  expression,  not  only  in  physiological  con-
itions,  but  also  in  human  disease.  The  word  ‘epigenetic’
s  deﬁned  as  heritable  changes  in  gene  expression  without
hanges  in  the  DNA  coding  sequences  [1]. Epigenetics  is  a
eveloping  area  of  research  in  many  biological  studies  and
as  now  become  a  potential  therapeutic  target  for  many
uman  diseases,  including  cancer.  One  of  the  major  epige-
etic  regulation  processes  is  DNA  methylation,  into  which  a
onsiderable  number  of  studies  have  been  made  [2,3].  How-
ver,  recent  progress  in  the  ﬁeld  of  epigenetic  research  has
evealed  that  various  regulatory  systems,  including  histone
odiﬁcation  and  dynamic  chromatin  structure,  are  involved
n  epigenetic  regulation.  In  this  article,  the  mechanism
f  chondrocyte  differentiation  is  ﬁrst  introduced  and  then
ecent  ﬁndings  about  epigenetic  regulation  of  chondrocyte
ifferentiation  are  reviewed,  focusing  on  DNA  methyla-
ion  and  histone  modiﬁcation.  It  is  well  established  that
iRNAs  regulate  diverse  biological  processes  both  post-
ranscriptionally  and  epigenetically.  However,  little  is  known
bout  the  direct  association  between  miRNA  and  epigenetic
rograms  in  mammalian  cells.  Therefore,  the  role  of  miRNA
n  cartilage  homeostasis  and  chondrocyte  differentiation,
hrough  post-transcriptional  regulation  as  a  part  of  miRNA
unction,  is  also  introduced.
. Mechanism of chondrocyte differentiation
he  majority  of  bones,  including  craniofacial  bones,  are
ormed  by  a  unique  biological  event  called  endochondral
one  formation  [4,5].  Endochondral  bone  formation  starts
ith  mesenchymal  cell  condensation  followed  by  differ-
ntiation  into  chondrocytes,  which  then  form  cartilage  by
roducing  an  abundant  extracellular  matrix  comprising,
ol2a1  (collagen  type  II,  alpha  1)  and  Acan  (aggrecan).  From
ere,  the  chondrocytes  undertake  sequential  steps  of  dif-
erentiation  into  proliferating,  hypertrophic  and  terminal
hondrocytes  (Fig.  1)  [4,5].  This  process  generates  the  chon-
rocyte  differentiation  layer  of  the  growth  plate.  Finally,
he  chondrocytes  die  by  apoptosis  and  are  replaced  by  bone
ormation  following  blood  vessel  invasion.  At  each  differ-
These  well-organized  chondrocyte  differentiation
processes  are  harmoniously  regulated  by  several  transcrip-
tion  factors  in  a temporal-spatial  manner  (Fig.  1).  At  the
beginning  of  chondrocyte  differentiation,  Sox9  (SRY-box  con-
taining  gene  9)  and  its  cofactors,  Sox5  (SRY-box  containing
gene  5)  and  Sox6  (SRY-box  containing  gene  6),  play  essential
roles  in  Col2a1  gene  expression  [6,7]  and  chondrocyte-
speciﬁc  Sox9-deﬁcient  mice  show  severe  defects  in  skeletal
development  [8].  In  humans,  mutation  of  the  SOX9  gene
causes  campomelic  dysplasia,  characterized  by  severe  chon-
drodysplasia  and  autosomal  sex  reversal  [9,10].  Moreover,
disruption  of  the  cis-regulatory  element  of  SOX9, which
leads  to  decreased  SOX9  transcription,  causes  Pierre  Robin
Sequence  characterized  by  cleft  palate  [11]. During  the
process  of  chondrocyte  hypertrophy,  expression  of  Mef2C
(myocyte-speciﬁc  enhancer  factor  2C),  Forkhead  box  (FoxA)
proteins,  and  Runx  (runt-related  transcription  factor)  family
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Mef2cntiation  step,  chondrocytes  produce  stage-speciﬁc  marker
enes.  These  include  Col2a1  and  Acan  in  proliferating  chon-
rocytes,  Ihh  (Indian  hedgehog)  and  Pth1r  (parathyroid
ormone  1  receptor)  in  pre-hypertrophic  chondrocytes,  and
ol10a1  (collagen,  type  X,  alpha  1)  and  Mmp13  (matrix  met-
lloproteinase  13)  in  hypertrophic  chondrocytes  (Fig.  1).
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M
tigure  1  Schematic  of  chondrocyte  differentiation  steps
uring  endochondral  bone  formation.  Endochondral  bone  for-
ation starts  with  mesenchymal  condensation  followed  by  the
equential  differentiation  steps  as  indicated  in  the  ﬁgure.
orphological  features,  speciﬁc  marker  genes,  and  essential
ranscription  factors  for  each  differentiation  step  are  shown.
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proteins,  including  Runx2  and  Runx3, is  critical  [12—14].
Runx2-  and  Runx3-deﬁcient  mice  show  delayed  chondrocyte
hypertrophy  and  Runx2  regulates  Ihh  expression  by  direct
binding  to  the  Ihh  gene  promoter  [12].  Interestingly,  Runx2
transgenic  mice  driven  by  the  Col2a1  gene  promoter  show
accelerated  chondrocyte  hypertrophy  in  proliferating
chondrocytes  where  hypertrophic  change  never  occurs  [15].
Furthermore,  Sox9  transgenic  mice,  using  Col2a1-Cre  mice,
have  delayed  chondrocyte  hypertrophy  [16]  suggesting  a
stage-speciﬁc  function  of  Sox9  and  Runx2  during  endo-
chondral  bone  formation.  In  addition,  Mef2c  activates  the
Col10a1  gene  promoter  and  heterozygous  deletion  of  Mef2c
has  been  show  to  result  in  abnormal  chondrocyte  hyper-
trophy  and  lack  of  ossiﬁcation  [13].  Chondrocyte-speciﬁc
deletion  of  transcription  factor  FoxA2  (Forkhead  box  protein
A2)  and  FoxA3  (Forkhead  box  protein  A3)  results  in  abnormal
endochondral  bone  formation  and  dwarﬁsm  because  of
the  reduction  in  hypertrophic  gene  expression,  including
Col10a1,  Alpl  (alkaline  phosphatase),  and  Mmp13  [14].
Gli  transcription  factors  play  essential  roles  in  endo-
chondral  bone  formation  by  activating  Ihh  signaling,  a
member  of  the  hedgehog  family.  Among  Gli  family  pro-
teins,  Gli2  is  a  major  signaling  molecule  of  Ihh-dependent
chondrogenesis  and  directly  regulates  chondrocytic  genes,
including  PTHrP  (parathyroid  hormone-related  protein),
Ptch1  (patched  homolog  1),  Col10a1,  and  Gli1  [17—20].
The  deletion  of  both  Ihh  and  Gli2  causes  severe  skeletal
defects  with  reduced  chondrocyte  proliferation  and  matu-
ration  [21—23].
Importantly,  these  transcription  factors  form  large  trans-
criptional  complex  machinery  to  regulate  gene  expression
and  do  not  induce  transcription  alone  [24].  For  instance,
Sox9  physically  interacts  with  various  transcriptional  co-
regulators,  including  Arid5a  (AT  rich  interactive  domain
5a),  p54nrb/NonO  (non-POU  domain  containing,  octamer-
binding),  Wwp2  (WW  domain  containing  E3  ubiquitin  protein
ligase  2),  Pgc1-alpha  (PPAR- co-activator-1  alpha),  Smad3
(Smad  family  member  3),  and  Znf219  (zinc  ﬁnger  protein
219)  [25—30].  Regarding  Gli2,  we  have  recently  reported
that  transcriptional  activity  of  Gli2  is  modulated  by  its  trans-
criptional  partner  Foxc1  (Forkhead  box  C1)  and  the  Ihh-Gli2
target  gene  expression  was  decreased  in  Foxc1  inactivated
mice  [31].  These  co-regulators  are  involved  in  multiple
steps  of  the  gene  expression  pathway,  including  mRNA
splicing,  chromatin  organization,  and  mRNA  maturation.
Furthermore,  different  combinations  of  these  transcriptio-
nal  co-regulators  modulate  each  step  of  the  gene  expression
pathway.  Of  note,  recent  studies  have  demonstrated  that
transcriptional  co-regulators  signiﬁcantly  contribute  to  the
epigenetic  regulatory  system,  including  DNA  methylation
and  histone  modiﬁcation  during  gene  expression.
3. DNA methylation
3.1.  DNA  methylation  and  chondrocyte
differentiationDNA  methylation  is  one  of  the  well-documented  epigenetic
regulatory  systems  for  gene  expression,  and  this  system
is  conserved  between  species.  This  process  occurs  on  the
carbon  5  position  of  cytosine  residues  of  CpG  dinucleotides.
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he  methylation  of  DNA  is  a  reversible  biological  process
nd  is  regulated  by  DNMTs  (DNA  methyltransferases)  [32].
hen  DNA  methylation  occurs  in  the  promoter  region  of
enes,  binding  of  the  speciﬁc  transcription  factors  to  their
inding  elements  is  inhibited,  which  in  turn  represses
ranscription.  DNA  methylation  also  causes  the  recruitment
f  transcriptional  repressors  to  the  methylated  region  of
he  gene  promoter.  In  addition,  several  reports  indicate
hat  DNA  methylation  can  control  chromatin  remodeling
nd  histone  modiﬁcations  [33,34].
It  is  well  established  that  DNA  methylation  is  involved
n  various  biological  events,  including  genomic  imprinting,
ancer  and  X  chromosome  inactivation  [35]. There  are  sev-
ral  reports  regarding  the  association  between  chondrocyte
ene  expression  and  DNA  methylation.  Zimmermann  et  al.
nvestigated  the  DNA  methylation  level  of  chondrocyte  gene
romoters  using  human  articular  cartilage  chondrocytes,
hich  exhibit  high  expression  of  Col2a1  but  not  Col10a1  [36].
hey  observed  that  the  Col10a1  gene  promoter  was  highly
ethylated,  whereas  the  transcriptional  start  site  of  the
ol2a1  gene  promoter  was  unmethylated.  DNA  meythylation
tatus  is  strongly  associated  with  chondrocyte  differentia-
ion  activity.  Hiramatsu  et  al.  generated  chondrogenic  cells
irectly  from  dermal  ﬁbroblasts  and  found  that  the  pro-
oter  of  the  Col1a1  gene  was  highly  methylated,  whereas
he  methylation  level  was  low  in  the  dermal  ﬁbroblasts
37]. These  data  indicate  that  control  of  DNA  methylation  in
he  chondrocyte  gene  promoter  is  important  for  successful
epair  of  cartilage  using  tissue  engineering  approaches.
.2.  DNA  methylation  and  cartilage  disease
everal  studies  have  reported  a  correlation  between  DNA
ethylation  and  cartilage  destruction  diseases,  includ-
ng  osteoarthritis  (OA)  [38—40].  Interestingly,  damaged
hondrocytes  in  OA  patients  show  an  increased  DNA  meth-
lation  level  in  the  Sox9  gene  promoter  compared  with
hat  of  normal  cartilage  [41],  suggesting  the  epigenetically
mpaired  chondrogenesis  in  OA  is  likely  due  to  the  decreased
xpression  of  Sox9. CpG  sites  in  the  Col9a1  gene  promoter
re  hypermethylated  in  the  cartilage  of  OA  patients  com-
ared  with  controls.  Furthermore,  impaired  Sox9  binding
o  the  Col9a1  gene  promoter  has  been  observed  in  OA
hondrocytes  [42].
In  addition  to  anabolic  genes,  a  role  for  DNA  methylation
s  also  reported  in  catabolic  gene  expression.  Roach  et  al.
ave  shown  that  the  methylation  status  of  CpG  sites  in  the
romoter  region  of  cartilage-degrading  enzymes,  including
MPs  and  a  member  of  the  ADAMTS  (a  distinegrin  and  metal-
oproteinase  with  thrombospondin  motifs)  family,  ADAMTS-
,  is  decreased  in  chondrocytes  from  OA  patients  compared
ith  normal  chondrocytes.  This  suggests  that  epigenetically
ncreased  gene  expression  of  these  enzymes  may  contribute
o  the  development  of  OA  [43].  Bui  et  al.  have  reported  that
emethylation  of  CpG  sites  located  in  the  proximal  promoter
f  MMP13  increases  the  binding  of  the  transcription  fac-
or  CREB,  which  in  turn  promotes  MMP13  gene  expression.
mportantly,  they  also  found  that  the  DNA  methylation  level
f  this  CREB  binding  region  is  reduced  in  human  chondro-
ytes  obtained  from  OA  patients  [44].  Demethylation  of  NF-
B  (nuclear  factor  kappa-light-chain-enhancer  of  activated
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Figure  2  Schematic  of  histone  acetylation  and  deacetylation
during  chondrocyte  differentiation.
When  histone  is  deacetylated,  chromatin  becomes  condensed
and inactive,  therefore  Sox9  is  unable  to  bind  to  the  Col2a1  gene
enhancer.  In  contrast,  histone  acetylation  causes  loose  packing
of chromatin,  which  makes  Sox9  more  accessible  and  allows
it to  bind  to  the  Col2a1  enhancer  region.  During  transcription
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 cells)  responsive  enhancer  elements  in  human  articular
hondrocytes  causes  abnormal  expression  of  inducible  nitric
xide  synthase  in  OA  patients  [45].  These  reports  indicate
hat  epigenetic  regulators  that  are  able  to  modulate  the
NA  methylation  level  of  cartilage  destructive  enzymes  are
otential  therapeutic  targets  for  cartilage  diseases.
. Histone modiﬁcation and chondrocyte
ifferentiation
ecause  the  dynamic  organization  of  the  chromatin  struc-
ure  is  inﬂuenced  by  histones,  which  make  up  the
ucleosome,  histone  modiﬁcation  largely  affects  the  gene
xpression  machinery  at  various  levels.  Recent  progress  in
he  epigenetic  ﬁeld  has  identiﬁed  and  characterized  eight
ypes  of  histone  modiﬁcation,  such  as  acetylation,  meth-
lation,  phosphorylation,  and  SUMOylation  [46].  There  is
rosstalk  between  histone  modiﬁcation  and  combinations  of
istone  modiﬁcation,  which  affects  transcription.  In  this  sec-
ion,  the  role  of  histone  acetylation  and  methylation  during
hondrocyte  differentiation  is  reviewed.
.1.  Histone  acetylation
istone  acetylation  is  a  well-studied  histone  modiﬁcation,
ith  a  considerable  number  of  studies  to  date  reporting  on
ts  functional  role  in  gene  expression  [47].  The  N-tail  of
istone  H3  contains  positively  charged  lysine  residues  and
hereby  strongly  binds  to  the  negatively  charged  DNA.  Lysine
cetylation  causes  neutralization  of  the  positive  charge  of
he  histone  tail,  which  reduces  the  binding  afﬁnity  of  histone
3  toward  DNA.  This  decreased  electrostatic  bond  strength
etween  histone  and  DNA  makes  the  nucleosomal  DNA  more
ccessible  and  allows  transcriptional  regulator  proteins,
ncluding  tissue-speciﬁc  transcription  factors  and  RNA  poly-
erase,  to  bind  to  the  transcription  sites  [48].  Based  on  this
echanism,  histone  acetylation  increases  transcriptional
ctivity  whereas  histone  deacetylation  inhibits  transcription
Fig.  2).  Histone  acetylases  (HATs)  and  histone  deacety-
ases  (HDACs)  physically  and  functionally  interact  with  the
roteins  that  constitute  the  transcriptional  machinery  and
egulate  gene  expression  [48,49].
During  chondrocyte  differentiation,  several  HAT  enzymes
re  reported  to  positively  regulate  chondrocyte  gene  expres-
ion  with  Sox9.  For  instance,  p300/CBP  physically  interacts
ith  Sox9  and  increases  the  acetylation  level  of  the  Sox9
arget  gene  promoter,  including  Col2a1  [50].  Moreover,  Hat-
ori  et  al.  searched  for  the  Sox9  binding  protein  using  a
east  two-hybrid  assay  and  identiﬁed  Tip60  (Tat  interactive
rotein-60),  which  belongs  to  the  MYST  family  of  the  HAT
nzymes  [51].  They  also  demonstrated  that  Tip60  is  involved
n  chromatin  organization  in  association  with  Sox9  and  Sox5.
In  addition  to  HATs,  several  studies  have  revealed  the
ole  of  HDACs  in  chondrocyte  differentiation.  Hang  et  al.
ave  reported  that  HDAC1  and  HDAC2  decrease  the  expres-
ion  of  Col2a1  and  aggrecan  gene  expression  [52]  and  Huh
t  al.  showed  that  HDAC  inhibitor  increases  Col2a1  gene
xpression  in  articular  chondrocytes  [53].  NAD-dependent
rotein  deacetylase,  Sirtuin1,  is  also  involved  in  the  regula-
ion  of  Col2a1  gene  expression  by  binding  to  the  chromatin
egion  of  the  Col2a1  gene  promoter  and  enhancer  [54].
M
s
e
hf Col2a1,  various  transcriptional  co-regulators  for  Sox9  are
ecruited  and  co-operatively  induce  gene  expression.
DAC4,  expressed  in  pre-hypertrophic  chondrocytes,  con-
rols  chondrocyte  hypertrophy  by  inhibiting  Runx2  function
55]. Moreover,  HDACs,  HDAC-1,  -2,  -3,  and  -7,  regulate
mp13  expression.  Inhibition  of  these  HDACs  protects  the
artilage  destruction  induced  by  IL-1  (interleukin-1),  sug-
esting  the  potential  therapeutic  use  of  HDAC  inhibitors
or  cytokine-induced  cartilage  degradation  observed  in  OA
56,57].
.2.  Histone  methylation
ethylation  has  been  recognized  as  a  common  protein
odiﬁcation  for  a  long  time.  However,  very  recently,
istone  methylation/demethylation  has  emerged  as  a  crit-
cal  step  for  transcription.  Similar  to  acetylation,  lysine
esidues  are  also  methylated,  but  there  are  three  types  of
ethyl-lysine  molecular  structures  including  mono-methyl
me1),  di-methyl  (me2)  and  tri-methyl  (me3).  As  described
n  the  previous  section,  histone  acetylation  reduces  the
ositive  charge  of  histone  proteins,  whereas  histone  meth-
lation  does  not  affect  their  charge.  However,  histone
ethylation/demethylation  results  in  both  transcriptional
epression  and  activation,  depending  on  the  target  site.
ethylation  at  H3K9  and  H3K27  inactivates  gene  expres-
ion,  while  H3K4  and  H3K36  methylation  activates  gene
xpression  [58—60]. Recent  studies  of  histone  methylation
ave  revealed  the  physiologic  and  pathologic  signiﬁcance
[
c
e
A
a
c
r
c
a
m
i
w
a
i
g
i
i
s
r
e
p
i
u
l
i
I
a
m
5
A
o
i
t
w
m
a
f
g
r
r
i
t
g
[
H
e
d
a
i
c
D
o
i
dEpigenetic  regulation  of  chondrocyte  differentiation  
of  histone  methylation  in  many  cellular  events,  includ-
ing  differentiation  and  proliferation  [61,62].  Rodova  et  al.
reported  that  the  promoter  region  of  the  transcription  fac-
tor  NFAT1  (nuclear  factor  of  activated  T  cells  1)  gene,
which  is  involved  in  OA  progression,  showed  an  increased
methylation  level  of  H3K4me2  but  decreased  methylation
level  of  H3K9me2  [63].  They  also  reported  that  lysine-
speciﬁc  demethylase-1  (Lsd1)  and  Jmjc-containing  histone
demethylase-2a  (Jhdm2a)  are  involved  in  the  regulation  of
lysine  methylation.  Herlofsen  et  al.  have  demonstrated  that
the  methylation  level  of  H3K4me3  and  H3K36me3  is  largely
associated  with  chondrocyte  differentiation  of  human  mes-
enchymal  stem  cells,  assessed  by  Chip-Seq  analysis  [64].
Setdb1  (SET  domain,  bifurcated1)  regulates  chondrocyte
hypertrophy  by  inhibiting  Runx2  activity  through  H3K9  meth-
ylation  [65,66].  However,  despite  its  signiﬁcance  in  gene
expression  pathways,  only  the  role  of  histone  acetylation
has  been  predominantly  studied  in  chondrogenesis,  with  lit-
tle  attention  given  to  the  regulatory  mechanism  of  histone
methylation/demethylation  during  chondrocyte  differentia-
tion.
In  light  of  this,  we  have  previously  attempted  to  uncover
the  physiological  signiﬁcance  of  histone  methylation  during
chondrocyte  differentiation  [67].  We  identiﬁed  Arid5b  (AT
rich  interactive  domain  5b)  as  a  transcriptional  co-regulator
of  Sox9,  by  performing  gene  expression  proﬁling  between
chondrogenic  cells  and  ﬁbroblasts,  the  latter  of  which  do
not  show  chondrogenic  activity.  Arid5b  was  highly  expressed
in  cartilage  tissue  and  synergistically  induced  chondrocyte
gene  expression  through  physical  and  functional  interac-
tions  with  Sox9.  Moreover,  we  showed  that  Arid5b  recruits
the  histone  demethylase,  Phf2,  to  chondrocyte  gene  promo-
ters,  including  Col2a1, and  decreases  the  methylation  level
of  H3K9me2,  a  repressive  marker  of  transcription.  These
data  collectively  indicated  that  Arid5b  promotes  chondro-
genesis  by  facilitating  a  relationship  between  Sox9  and
Phf2-mediated  histone  demethylation  of  chondrogenic  gene
promoters  and  establishes  a  novel  epigenomic  mechanism
of  endochondral  bone  development  [67].
5. miRNAs and chondrocyte differentiation
miRNAs  are  small  non-coding  RNAs  comprising  about  22
nucleotides.  miRNA  is  ﬁrst  synthesized  as  primary  miRNA  and
subsequently  truncated  into  the  pre-miRNA  by  ribonuclease.
Pre-miRNA  is  then  transported  into  the  cytoplasm  and  con-
verted  into  the  functional  and  mature  miRNA  by  Dicer,  which
is  an  essential  player  in  the  biogenesis  of  miRNAs.  Finally,
miRNA  forms  a  protein  complex  called  RISC  (RNA-induced
silencing  complex),  which  destroys  the  target  mRNAs.  miR-
NAs  regulate  target  gene  expression  by  directly  binding
to  the  sequence-speciﬁc  elements  located  in  their  target
RNAs.  Thus,  miRNA  controls  gene  expression  at  the  post-
transcriptional  stage  and  just  one  miRNA  targets  hundreds
of  genes.
The  important  roles  of  miRNA  in  chondrocyte  differenti-
ation  were  ﬁrst  described  by  Kobayashi  et  al.  by  generating
chondrocyte-speciﬁc  Dicer-deﬁcient  mice,  resulting  in  the
global  deletion  of  miRNAs  in  chondrocytes.  Dicer-deﬁcient
mice  show  severe  defects  in  skeletal  development  and  a
reduction  in  chondrocyte  proliferation  and  differentiation
t
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68]. These  data  suggest  that  miRNAs  play  some  roles  in
artilage  development  and  homeostasis.
It  is  well  established  that  miRNA  modulates  gene
xpression  both  post-transcriptionally  and  epigenetically.
lthough,  there  has  been  no  evidence  which  shows  the  direct
ssociation  between  miRNA  and  epigenetic  regulation  during
hondrocyte  differentiation,  miRNA  can  act  as  an  epigenetic
egulator  during  chondrogenesis.  Previous  studies  have  indi-
ated  that  epigenetic  modiﬁcation  enzymes,  such  as  DNMTs,
re  controlled  by  miRNAs  [69,70].  Interestingly,  several
iRNAs  can  recruit  chromatin-modifying  proteins,  includ-
ng  histone  methyltransferases,  through  physical  interaction
ith  Ago2  (Argonaute2),  which  increases  the  chromatin
ccesibility  and  transcription  [71]. These  reports  strongly
ndicate  that  miRNA  epigenetically  regulates  chondrocyte
ene  expression.  To  date  however,  chromatin  remodel-
ng,  DNA  methylation  and  histone  modiﬁcation  by  miRNA
n  mammalian  cells  is  largely  unreported.  Moreover,  most
tudies  focus  on  the  miRNA-dependent  post-transcriptional
egulation.  Post-transcriptional  regulation  by  miRNA  is  not
pigenetic  in  the  strict  sense  but  regulates  diverse  biological
rocesses.  Thus,  it  is  impossible  to  ignore  the  role  of  miRNA
n  order  to  better  understand  the  molecular  mechanisms
nderlying  chondrocyte  differentiation.  Indeed,  accumu-
ating  evidence  indicates  the  important  roles  of  miRNA
n  cartilage  homeostasis  and  chondrocyte  differentiation.
n  the  last  section  of  this  review,  the  role  of  miRNA
s  a  part  of  miRNA  function  is  introduced,  focusing  on
iR-140.
.1.  miR-140  and  chondrocyte  differentiation
lthough  almost  1000  miRNAs  are  reported,  miR-140  is
ne  of  the  chondrocyte-speciﬁc  miRNAs.  Previous  reports
ndicate  that  miR-140  is  speciﬁcally  expressed  in  cartilage
issue  in  both  zebraﬁsh  and  mice  [72,73].  In  accordance
ith  the  speciﬁc  expression  of  miR-140  in  chondrocytes,
iR-140  is  reported  to  be  associated  with  Sox9  function
nd  expression.  For  example,  miR-140  is  biosynthesized
rom  intron  16  of  the  Wwp2  gene,  which  is  the  direct  tar-
et  gene  of  Sox9  [74,75]. Yamashita  et  al.  found  a  Sox9
esponse  element  located  in  the  upstream  of  miR-140  and
eported  that  Sox9-dependent  miR-140  expression  is  further
ncreased  by  addition  of  Sox5  and  Sox6  [76]. In  addition
o  Sox9,  miR-140  also  regulates  the  expression  of  various
enes  involved  in  chondrogenesis,  including  Smad3  and  Rala
77,78].  In  particular,  several  groups  have  reported  that
DAC4  is  the  direct  target  gene  of  miR140  [72,79].  HDAC4  is
xpressed  in  proliferating  chondrocytes  and  inhibits  chon-
rocyte  hypertrophy  by  decreasing  Runx2  transcriptional
ctivity  [55].  These  reports  indicate  that  miR-140  indirectly
nhibits  chondrocyte  hypertrophy,  which  maintains  chondro-
yte  proliferation.  Moreover,  Nakamura  et  al.  reported  that
npep,  which  regulates  BMP  signaling,  is  the  target  gene
f  miR-140  in  chondrocytes  [80]. These  reports  collectively
ndicate  the  multifunctional  role  of  miR-140  during  chon-
rocyte  differentiation  and  further  analysis  of  the  miR-140
arget  gene  would  contribute  to  a better  understanding  of
hondrocyte  differentiation  (Fig.  3).
Although  deletion  of  miR-140  in  mice  results  in  a
lightly  dwarf  phenotype  with  shortened  limbs,  these  mice
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Figure  3  The  role  of  miR-140  in  chondrocyte  differentiation.
miR-140  is  generated  from  intron  16  of  the  Wwp2  gene  and
is directly  regulated  by  Sox9  and  its  cofactors  Sox5/6.  miR140
plays important  roles  in  endochondral  bone  formation  and  car-
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[7] Lefebvre V, Li P, de Crombrugghe B. A new long form of Sox5ilage homeostasis  through  regulating  Dnpep,  Hdac4,  Adamts5
nd Igfbp5.
xhibit  an  age-dependent  OA  phenotype  [81].  This  suggests
nvolvement  of  miR-140  not  only  in  the  physiological
ondition,  but  also  in  the  pathological  condition  for  the
aintenance  of  cartilage  tissue.  miR-140  has  also  been
emonstrated  to  directly  regulate  ADAMTS5  expression,
hich  is  strongly  associated  with  OA  progression  [81,82].
ardif  et  al.  found  that  the  expression  of  IGFBP5  (insulin
rowth  factor  binding  protein-5)  in  human  OA  chondrocytes
as  signiﬁcantly  lower  than  that  of  controls  and  that  IGFBP5
s  the  direct  target  of  miR-140  [83].  These  data  suggest
hat  miR-140  is  essential  for  cartilage  homeostasis  in  both
eveloping  and  adult  stages  and  a  candidate  therapeutic
arget  for  OA  treatment  (Fig.  3).
.2.  Other  miRNAs  and  chondrocyte
ifferentiation
n  addition  to  miR-140,  other  miRNAs  have  been  identiﬁed
s  regulators  of  chondrocyte  differentiation.  Several  groups
ave  shown  that  the  expression  of  miR-145  decreases  dur-
ng  chondrocyte  differentiation  of  mesenchymal  cells  and
ox9  is  the  direct  target  gene  of  miR-145  [84,85]. Over-
xpression  of  miR-145  inhibits  chondrocyte  differentiation
y  the  reduction  of  chondrocyte  gene  expression,  includ-
ng  Col2a1  and  aggrecan,  whereas  inhibition  of  miR-145
romotes  chondrocyte  differentiation  [84].  Furthermore,
iR-495,  miR-101,  and  miR1247  are  also  reported  to  directly
egulate  Sox9  expression  and  inhibit  chondrocyte  differen-
iation  [86—88].  In  contrast,  Sox9  up-regulates  miR-574-3p,
hich  inhibits  chondrocyte  differentiation  [89]. Overex-
ression  of  miR-675  increases  Col2a1  expression  in  human
hondrocytes  and  BMP2-responsive  miR-199a  controls  chon-
rocyte  differentiation  though  regulating  Smad1  [90,91].
lthough  many  miRNAs  have  been  identiﬁed  as  regulators  of
hondrocyte  differentiation,  the  signiﬁcance  of  these  in  vivo
emains  to  be  elucidated.K.  Hata
. Conclusions
pigenetic  regulation  is  now  noted  as  a  critical  biological
rocess  and  is  well  documented  in  many  research  ﬁelds,
owever  little  is  known  about  the  role  of  epigenetics  in
keletal  development.  Recent  studies  have  shown  remark-
ble  progress  in  epigenetic  research  owing  to  advanced
echnologies,  including  deep  sequencing  and  bioinformatics.
n  addition  to  basic  research,  epigenetic  regulators  are  rec-
gnized  as  an  effective  therapeutic  target  for  many  diseases
92]  and  regenerative  medicine  using  induced  pluripotent
tem  cells  [93].  However,  histone  acetylation  and  methyl-
tion  are  not  the  only  processes  for  histone  modiﬁcation,
nd  various  combinations  may  affect  the  gene  expres-
ion.  Although  little  is  known  about  the  direct  association
etween  miRNA  and  chromatin  modiﬁcation  in  mammals,
egulatory  mechanisms  underlying  miRNA-dependent  epi-
enetic  regulation  during  chondrocyte  differentiation  are
f  interest.  It  should  be  noted  that  miRNA  is  a  critical
egulator  for  post-transcriptional  gene  expression  and  rep-
esents  a  promising  therapeutic  target.  Further  advances  in
pigenetic  regulation  of  chondrocyte  differentiation  would
ontribute  to  the  development  of  treatments  and  therapies
or  cartilage  diseases  such  as  OA.
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